However, it is not satisfactory that AFP is a biomarker in the early diagnosis of HCC, because of the limited sensitivity and specificity of AFP in the diagnosis of hepatocellular carcinoma with some false negative and false positive, which greatly limits the clinical application prospect of AFP in monitoring HCC. The gene discussed is AFP; the disease is hepatocellular carcinoma.